MedPath

Pilot study to distinguish between intracerebral hemorrhage and ischemic stroke using a non-invasive acustoscerebrography in combination with established serum biomarkers.

Conditions
I63
I61
Cerebral infarction
Intracerebral haemorrhage
Registration Number
DRKS00021724
Lead Sponsor
ZNN, Klinik für Neurologie Universitätsklinikum Frankfurt a.M.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

(1) age = 18 years
(2) Relevant neurological deficit, National Institute of Health Stroke Scale (NIHSS) =6
(3) Admission to hospital within 6 hours of symptom onset.
(4) Evidence of an occlusion of the M1- or M2-artery on computed tomography (CT)-angiography or evidence of intracerebral hemorrhage in a supratentorial location

Exclusion Criteria

(1) Prior history of stroke (TIA, ischemia, hemorrhage) within the last months.
(2) Known history of brain Tumor
(3) Traumatic brain injury within the last 3 months (including head impact at symptom onset)

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Description of a specific pattern of multispectral ultrasound distinguishing patients with ischemic from hemorrhagic strokes.
Secondary Outcome Measures
NameTimeMethod
(1) GFAP Serum Level (including a comparison of diagnostic accuracy with the ultrasound results)<br>(2) Volumetry of intracerebral hemorrhage according to the axbxc^2-method<br>(3) Severity of the clinical neurological deficit on hospital admission according to the National Institute of Health Stroke Scale <br>(4) Time between symptom onset and collection of blood sample <br>
© Copyright 2025. All Rights Reserved by MedPath